Daniel de Boer is a passionate entrepreneur with a drive to make a meaningful impact on society. Initially, he was focused on building IT companies; however, when his newborn son was diagnosed with cystic fibrosis, a life-threatening disease with a limited life expectancy, it put everything in his life into perspective. de Boer decided to turn his focus towards finding a treatment for his son and other patients suffering from cystic fibrosis. He founded ProQR Therapeutics, which currently has 150 employees across Europe and the United States. Inspired by his work for cystic fibrosis patients and with a goal to impact many more lives, de Boer decided to broaden the scope of ProQR to include developing drugs for several other severe, rare diseases for which no treatments are available.